Products-banner

Products

Lifecosm SARS-CoV-2 & Influenza A/B Antigen Combo Test Cassette

Product Code:

Item Name: SARS-CoV-2 & Influenza A/B Antigen Combo Test Cassette

Summary:The SARS-CoV-2 & Influenza A/B Antigen Combo Test Cassette is applicable to the simultaneous qualitative detection and differentiation of novel Coronavirus (SARS-CoV-2 Antigen), Influenza A virus, and/or Influenza B virus Antigen in population Oropharyngeal swabs and Nasopharyngeal swabs samples in vitro.

Principle: One-step immunochromatographic assay

Detection Targets: COVID-19 Antigen and Influenza A/B Antigen

Reading time: 10 ~ 15 minutes

Storage: Room Temperature (at 2 ~ 30℃)

Expiration: 24 months after manufacturing


Product Detail

Product Tags

Introduction

Summary Detection of specific Antigen of Covid-19 & Influenza A/B  within 15 minutes
Principle One-step immunochromatographic assay
Detection Targets Covid-19 & Influenza A/B Antigen
Sample    Nasopharyngeal Swab,Oropharyngeal Swab
Reading time 10~ 15 minutes
Quantity 1 box (kit) = 25 devices (Individual packing)
Contents 25 Test Cassettes: each cassette with desiccant in individual foil pouch 25 Sterilized Swabs: single use swab for specimen collection

25 Extraction Tubes: containing 0.4mL of extraction reagent

25 Dropper Tips

1 Work Station

1 Package Insert

  

Caution

Use within 10 minutes after openingUse appropriate amount of sample (0.1 ml of a dropper)

Use after 15~30 minutes at RT if they are stored under cold circumstances

Consider the test results as invalid after 10 minutes

INTENDED USE

The SARS-CoV-2 & Influenza A/B Antigen Combo Test Cassette is applicable to the simultaneous qualitative detection and differentiation of novel Coronavirus (SARS-CoV-2 Antigen), Influenza A virus, and/or Influenza B virus Antigen in population Oropharyngeal swabs and Nasopharyngeal swabs samples in vitro.

PRINCIPLE

The SARS-CoV-2 & Influenza A/B Antigen is qualitatively detected in population Oropharyngeal swabs and Nasopharyngeal swabs samples by the colloidal gold method. After sample added, the SARS-CoV-2 Antigen (or Influenza A/B) in the sample to be tested is combined with the SARS-CoV-2 Antigen (or Influenza A/B) antibody labelled with colloidal gold on the binding pad to form the SARS-CoV-2 Antigen (or Influenza A/B) antibody-colloidal gold complex. Due to chromatography, the SARS-CoV-2 Antigen (or Influenza A/B)-antibody-colloidal gold complex diffuses along the nitrocellulose’s membrane. Within the detection line area, the SARS-CoV-2 Antigen (or Influenza A/B)-antibody complex binds to the antibody enclosed within the detection line area, showing a purple-red band. Colloidal gold labelled SARS-CoV-2 Antigen (or Influenza A/B) antibody diffuses to the quality control line (C) region and is captured by sheep anti-mouse IgG to form red bands. When the reaction is over, the results can be interpreted by visual observation.

COMPOSITION

Materials Provided

●25 Test Cassettes: each cassette with desiccant in individual foil pouch
●25 Sterilized Swabs: single use swab for specimen collection
●25 Extraction Tubes: containing 0.4mL of extraction reagent
●25 Dropper Tips
●1 SARS-CoV-2 antigen positive control swab (optional)
●1 flu A antigen positive control swab (optional)
●1 flu B antigen positive control swab (optional)
●1 negative control swab (optional)
●1 Work Station
●1 Package Insert

Materials Required but not Provided

●Timer


  • Previous:
  • Next:

  • Write your message here and send it to us